The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Shanghai Dermatology Hospital

Status: Enrolling

Conditions: Sensitive Skin

Treatments: Drug: bFGF; Drug: Bovine Basic Gel

Study type: Interventional

Funder types: Other

Identifiers

NCT06516939

2024-06

Details and patient eligibility

About

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Enrollment: 28 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3
2. No related skin care products including bovine alkaline fibroblast growth factor were used within 1 month before participating in the experiment, and photoelectric treatment measures were not carried out
3. Physical sunscreen should be strict during enrollment

Exclusion criteria

1. Children
2. Have serious heart, liver, kidney, and blood system diseases, and severe immunocompromise
3. Patients with mental illness or cancer
4. Those who have received glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics or tretinoin within 3 months
5. Those who are allergic to basic fibroblast growth factor gel and its components
6. Acute dermatitis of the face and perifolliculitis

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

28 participants in 2 patient groups, including a placebo group

The Application of Bovine Basic Fibroblast Growth Factor Gel

Experimental group

Treatment:

Drug: bFGF

Bovine Basic Gel

Placebo Comparator group

Treatment:

Drug: Bovine Basic Gel